Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake

Ticagrelor is an antagonist of both platelet adenosine diphosphate (ADP) receptor P2Y12 and equilibrative nucleoside transporter-1. Optimal timing of ticagrelor cessation prior to coronary artery bypass grafting (CABG) remains unclear. We characterized the offset of ticagrelor’s effects on platelets...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Kok Weng Ow, William A.E. Parker, Mark M. Porter, Jessica Hanson, Heather M. Judge, Norman P. Briffa, Mark R. Thomas, Robert F. Storey
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Taylor & Francis Group 2020-10-01
Serie:	Platelets
Ämnen:	acute coronary syndrome adenosine coronary artery bypass graft surgery platelets ticagrelor
Länkar:	http://dx.doi.org/10.1080/09537104.2019.1709631
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!